by Eric Christianson | Jan 21, 2026 | Polypharmacy Cases And The Prescribing Cascade
One of the biggest contributors to polypharmacy isn’t the number of diagnoses a patient has—it’s our mindset around medications that fail to deliver benefit. Everyone knows we need to reduce meds in geriatrics, but how do we do that? Too often, when a drug doesn’t...
by Eric Christianson | Jan 7, 2026 | Polypharmacy Cases And The Prescribing Cascade
Mr. H is a 78-year-old male presenting to a primary care clinic for a routine medication review. In this scenario, we want to identify deprescribing targets. His past medical history includes hypertension, heart failure with preserved ejection fraction (HFpEF),...
by Eric Christianson | Oct 1, 2025 | Polypharmacy Cases And The Prescribing Cascade
I was asked a question the other day about trying to reduce medications in a patient on hospice. More specifically, how to address the use of PPIs. Proton pump inhibitors (PPIs) are some of the most overused medications we see in clinical practice, but hospice...
by Eric Christianson | Jun 1, 2025 | Hematology and Immunology Medication and Disease State Clinical Pearls, Uncategorized
When patients have anemia, supplements often get prescribed. To many of our polypharmacy patients, excessive prescribing can lead to an increase in pill burden that may not always be necessary. When looking at deprescribing supplements, anemia is an excellent disease...
by Eric Christianson | Apr 6, 2025 | Polypharmacy Cases And The Prescribing Cascade
Deprescribing is an important part of care for hospice patients. The main goal of hospice care is to focus on comfort care rather than curative treatments, which means evaluating if a patient’s current medications are still indicated, effective, safe, and convenient....
